Skin rash during chronic hepatitis C therapy

Gastroenterology and Hepatology

Volumn 6, Issue 5, 2010, Pages 323-325

  Veluru, Chandra ^a   Atluri, Dileep ^a   Chadalavada, Rajagopal ^a   Burns, Elke ^a   Mullen, Kevin D ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HUMAN; SKIN DEFECT; TREATMENT OUTCOME;

EID: 77953297921     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-714.
2. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998;339:1485-1492.
3. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet. 2001;358:958-965.
4. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-982.
5. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology. 2002;36:S237-S244.
6. Stryjek-Kaminska D, Ochsendorf F, Röder C, Wolter M, Zeuzem S. Photoallergic skin reaction to ribavirin. Am J Gastroenterol. 1999;94:1686-1688.
7. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol. 2002;147:1142-1146.
8. Savk E, Uslu G, Karaoǧlu AO, Sendur N, Karaman G. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C. J Eur Acad Dermatol Venereol. 2005;19:396-398.
9. Hashimoto Y, Kanto H, Itoh M. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. J Dermatol. 2007;34:577-582.